arrow_back Back Filing freshness 10-Q Q3 FY2026 SEC EDGAR

BECTON DICKINSON & CO

BDX
$182.50 ▼ -0.52 (-0.28%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
75 Visible periods
34 Metrics
Peer-ranked Benchmarks
Price Chart
58
Health
Fair
Neutral
auto_awesome

Analytical Summary

BECTON DICKINSON & CO shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $50.1B
Dividend Yield 0.58%
Revenue Growth -9.5%
Op. Margin 13.3%
ROIC 1.4%
FCF / Share None
Trailing P/E 133.2x
Price / Book 2.1x
FCF Yield
Debt / Equity 0.55
info Valuation on last close. End-of-day price, Sep 23, 2026.

75-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$4.98B
↓ -9.5%
Net Income Profit after all expenses
$377.00M
↓ -34.3%
Operating Margin Operating profit as % of sales
13.3%
↑ +574.4% 60th
FCF / Share Free cash flow per share
$1.92
↑ +23.5%
Long-Term Debt Long-term obligations
$13.51B
↓ -8.1%

Health Breakdown

Profitability
60
Returns
58
Financial Health
55

Dividend History

Dividend / share · sourced from SEC filings
$4.16 Latest / share
+9.5% YoY
+6.1% 12-yr CAGR

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 20 years · 75 quarters